[1]
|
Weiner, H.L. (2004) Multiple Sclerosis Is an Inflammatory T-Cell-Mediated Autoimmune Disease. Archives of Neurology, 61, 1613. http://dx.doi.org/10.1001/archneur.61.10.1613
|
[2]
|
Compston, A. and Coles, A. (2008) Multiple Sclerosis. Lancet, 372, 1502. http://dx.doi.org/10.1016/S0140-6736(08)61620-7
|
[3]
|
Goodin, D.S. (2014) The Epidemiology of Multiple Sclerosis: Insights to Disease Pathogenesis. Handbook of Clinical Neurology, 122, 231. http://dx.doi.org/10.1016/B978-0-444-52001-2.00010-8
|
[4]
|
Nylander, A. and Hafler, D.A. (2012) Multiple Sclerosis. Journal of Clinical Investigation, 122, 1180. http://dx.doi.org/10.1172/JCI58649
|
[5]
|
Roach, E.S. (2004) Is Multiple Sclerosis an Autoimmune Disorder? Archives of Neurology, 61, 1615. http://dx.doi.org/10.1001/archneur.61.10.1615
|
[6]
|
Ascherio, A. and Munger, K.L. (2007) Environmental Risk Factors for Multiple Sclerosis. Part II: Noninfectious Factors. Archives of Neurology, 61, 504.
|
[7]
|
Van der Mei, I.A., Ponsonby, A.L., Dwyer, T., et al. (2003) Past Exposure to Sun, Skin Phenotype, and Risk of Multiple Sclerosis: Case-Control Study. BMJ, 327, 316. http://dx.doi.org/10.1136/bmj.327.7410.316
|
[8]
|
Islam, T., Gauderman, W.J., Cozen, W. and Mack, T.M. (2007) Childhood Sun Exposure Influences Risk of Multiple Sclerosis in Monozygotic Twins. Neurology, 69, 381. http://dx.doi.org/10.1212/01.wnl.0000268266.50850.48
|
[9]
|
Orton, S.M., Wald, L., Confavreux, C., et al. (2011) Association of UV Radiation with Multiple Sclerosis Prevalence and Sex Ratio in France. Neurology, 76, 425. http://dx.doi.org/10.1212/WNL.0b013e31820a0a9f
|
[10]
|
Ramagopalan, S.V., Handel, A.E., Giovannoni, G., et al. (2011) Relationship of UV Exposure to Prevalence of Multiple Sclerosis in England. Neurology, 76, 1410. http://dx.doi.org/10.1212/WNL.0b013e318216715e
|
[11]
|
Salzer, J., Hallmans, G., Nyström, M., et al. (2012) Vitamin D as a Protective Factor in Multiple Sclerosis. Neurology, 79, 2140. http://dx.doi.org/10.1212/WNL.0b013e3182752ea8
|
[12]
|
Munger, K.L., Zhang, S.M., O’Reilly, E., et al. (2004) Vitamin D Intake and Incidence of Multiple Sclerosis. Neurology, 62, 60. http://dx.doi.org/10.1212/01.WNL.0000101723.79681.38
|
[13]
|
Mowry, E.M., Waubant, E., McCulloch, C.E., et al. (2012) Vitamin D Status Predicts New Brain Magnetic Resonance Imaging Activity in Multiple Sclerosis. Annals of Neurology, 72, 234. http://dx.doi.org/10.1002/ana.23591
|
[14]
|
Ascherio, A., Munger, K.L., White, R., et al. (2014) Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression. JAMA Neurology, 71, 306. http://dx.doi.org/10.1001/jamaneurol.2013.5993
|
[15]
|
Smolders, J., et al. (2008) Association of Vitamin D Metabolite Levels with Relapse Rate and Disability in Multiple Sclerosis. Multiple Sclerosis, 14, 1220-1224. http://dx.doi.org/10.1177/1352458508094399
|
[16]
|
Correale, J., et al. (2009) Immunomodulatory Effects of Vitamin D in Multiple Sclerosis. Brain, 132, 1146-1160. http://dx.doi.org/10.1093/brain/awp033
|
[17]
|
Van der Mei, I.A., et al. (2007) Vitamin D Levels in People with Multiple Sclerosis and Community Controls in Tasmania, Australia. Journal of Neurology, 254, 581-590. http://dx.doi.org/10.1007/s00415-006-0315-8
|
[18]
|
Runia, T.F., et al. (2012) Lower Serum Vitamin D Levels Are Associated with a Higher Relapse Risk in Multiple Sclerosis. Neurology, 79, 261-266. http://dx.doi.org/10.1212/WNL.0b013e31825fdec7
|